Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase

This article was originally published in The Tan Sheet

Executive Summary

Cardinal Health is adding to its contract manufacturing business with the approximately $390 mil. acquisition of Automatic Liquid Packaging, which manufactures Rx and OTC sterile liquid pharmaceuticals and other health care products. Dublin, Ohio-based Cardinal announced the acquisition agreement with privately held ALP of Woodstock, Ill. Aug. 5.

You may also be interested in...



Cardinal making $2.4 bil. move into contract drug manufacturing with R.P. Scherer buy.

SCHERER IS CARDINAL ENTRY INTO CONTRACT MANUFACTURING with the wholesaler's addition of 19 production facilities in 12 countries through the $2.4 bil. acquisition of the drug delivery system developer and contract manufacturer R.P. Scherer announced May 18. The agreement will significantly expand Cardinal Health's fledgling contract manufacturing business developed through its PCI and National PharmPak repackaging operations.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel